Effects of silymarin on p65 NF-κB, p38 MAPK and CYP450 in LPS-induced hoof dermal inflammatory cells of dairy cows

BMC Vet Res. 2019 Apr 30;15(1):127. doi: 10.1186/s12917-019-1868-y.

Abstract

Background: Laminitis is considered as one of the most important causes of hoof lameness in dairy cows, which can lead to enormous economic losses. However, the etiology and pathogenesis of laminitis have not been clarified yet. Besides, it is of great significant to find alternative herbs for the prevention and treatment of dairy hooves to avoid the antibiotic abuse. In this study, the primary hoof dermal cells of dairy cows were isolated, the inflammatory model was induced by LPS, and treated with silymarin to find whether silymarin has protective effect on the inflammatory dermal cells. The viability of dermal cells, the levels of IL-1β and TNF-α, the degree of p65 NF-κB and p38 MAPK phosphorylation, the expressions of CYP3A4 and CYP1A1 were measured.

Results: Hoof dermal cells of dairy cows were successfully isolated and cultured by tissue adherent culture method. Certain concentrations of LPS can increase the levels of IL-1β and TNF-α, promote the phosphorylation of p65 NF-κB and p38 MAPK, and inhibit the mRNA expressions of CYP3A4 and CYP1A1. The optimal concentration for LPS to establish a hoof dermal cells inflammatory model was 10 μg/mL. Certain concentrations of silymarin can markedly decrease the secretions of IL-1β and TNF-α, inhibit the phosphorylation of p65 NF-κB and p38 MAPK, and promote the mRNA expressions of CYP3A4 and CYP1A1 in LPS-induced dermal inflammatory model.

Conclusions: LPS can be used for inducing the hoof dermal cells inflammatory model of dairy cows. Silymarin has protective effects on the LPS-induced inflammatory model.

Keywords: Dairy cow; Hoof dermal cell; Silymarin.

MeSH terms

  • Animals
  • Cattle
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cytochrome P-450 CYP1A1 / genetics
  • Cytochrome P-450 CYP1A1 / metabolism
  • Cytochrome P-450 CYP3A / genetics
  • Cytochrome P-450 CYP3A / metabolism
  • Cytochrome P-450 Enzyme System / genetics
  • Cytochrome P-450 Enzyme System / metabolism*
  • Dermis / cytology
  • Dermis / drug effects
  • Gene Expression Regulation / drug effects
  • Hoof and Claw / cytology*
  • Hoof and Claw / drug effects
  • Inflammation / chemically induced
  • Interleukin-1beta / metabolism
  • Lipopolysaccharides / toxicity
  • Phosphorylation
  • Silymarin / pharmacology*
  • Transcription Factor RelA / genetics
  • Transcription Factor RelA / metabolism*
  • Tumor Necrosis Factor-alpha / metabolism
  • p38 Mitogen-Activated Protein Kinases / genetics
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Interleukin-1beta
  • Lipopolysaccharides
  • Silymarin
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • Cytochrome P-450 Enzyme System
  • Cytochrome P-450 CYP1A1
  • Cytochrome P-450 CYP3A
  • p38 Mitogen-Activated Protein Kinases